Repurposing Central Nervous System (CNS) Drugs as Chemotherapeutic Agents.
Journal: Current Medicinal Chemistry
Guest Editor(s): Dr. G. Lentini
Co-Guest Editor(s): Dr. Maria Maddalena Cavalluzzi,Dr. Serge Mignani
Submission closes on:
31st December, 2025
Introduction
During the COVID-19 pandemic, numerous reports indicated that the infection found apparent resistance within the hospitalized psychiatric population. Thus, the hypothesis was formulated that some psychiatric drugs might be endowed with antiviral activity. This thematic issue welcomes collections of both original and review papers highlighting the drug repurposing landscape regarding CNS agents as a strategy to identify new chemotherapeutics.
Keywords
Antiviral, antibacterial, anti-cancer, antiparasitic, antifungal, phytotherapy, psychotropic.
Sub-topics
Ø CNS drug repositioning for viral infections
Ø Repurposing CNS drugs as antiproliferative agents
Ø CNS drug repositioning for bacterial infections
Ø CNS drug repositioning for fungal infections
Ø CNS drug repositioning for rare diseases
Ø CNS drug repositioning for parasitic infestation
Ø Repurposing CNS herbal medicines as chemotherapic agents
Ø Computational methods to facilitate CNS drug repositioning as chemotherapeutics.